Select your Market

Why Invest

Combining expertise in biology, chemistry and physics with data and AI, we develop cutting edge products and solutions and deliver sustainable value and growth for our stakeholders and society.

It’s a great idea to invest in us – and here’s why

Related News

View All News
  1. Press Releases

    Merck KGaA, Darmstadt, Germany, Announces FDA Breakthrough Therapy Designation ...

    The Company announced that the FDA has granted Breakthrough Therapy designation to enpatoran

    2026/07/08

  2. Press Releases

    Merck KGaA, Darmstadt, Germany, Agrees to Acquire Bio-Techne, Strengthening ...

    Purchase price of US$73 per share in cash represents an enterprise value of US$11.3 billion (EUR 9.9 billion).

    2026/06/25

  3. Press Releases

    MilliporeSigma Announces Hiba Therapeutics as Winner of 2026 North American ...

    Hiba Therapeutics winner of the 2026 North American Advance Biotech Grant at the 2026 BIO International Convention.

    2026/06/24

investors-shareprice2 investors-shareprice2
Share Price
Check Share Price
Share Price
Our interactive Share Price Tool provides you with all the information you need. You can retrace our development within the last ten years or follow it in real time – or compare our share price to various indices.
453077651 453077651
Financials
Read More
Financials
Our Financial Reporting Center offers you the opportunity to select from financial data on an annual or quarterly basis.